Case report: cavernous hemangioma of the liver.
Although cavernous hemangioma is the most common benign tumor of the liver, controversy persists regarding diagnosis and management of these lesions. With the development of multiple noninvasive modalities to visualize the liver, hepatic cavernous hemangiomas are recognized with increased frequency. The authors report the unusual case of a post-menopausal woman on no exogenous estrogen therapy who had a cavernous hemangioma that remained stable for approximately 10 years before dramatically increasing in size. This patient illustrates the vague symptoms associated with cavernous hemangiomas and the unpredictability of growth. Although estrogens have been reported trophic, this patient had no exogenous or endogenous estrogen supply, yet her lesion reached massive proportions. Modalities necessary to assure accurate diagnosis and factors influential in management are discussed.
DuPre
C T
CT
Medical College of Georgia School of Medicine, Department of Medicine, Augusta 30912.
Fincher
R M
RM
D000328:Adult; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D006392:Hemangioma, Cavernous / Q000175:diagnosis / Q000473:pathology* / Q000601:surgery; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000473:pathology* / Q000601:surgery
D004967:Estrogens